9th Annual Role of Cardiac Imaging in Women

9th Annual Role of Cardiac Imaging in Women is organized by Cardiovascular Institute (CVI) of Philadelphia and will be held on Dec 03, 2022 at The Westin Mount Laurel, Mount Laurel, New Jersey, United States of America.

Overview:
The 9th Annual Role of Cardiac Imaging in Women CME Program is designed to further the clinical application management and interpretation skills of physicians, technologists and advanced practice providers involved in non-invasive cardiac imaging.  The agenda for the program focuses on a variety of topics in non-invasive cardiac imaging including:  Assessment of cardiovascular risk in women; risks and management of hypertension in pregnancy; cardiovascular morbidity and mortality for women in 2022; diagnosis and management of INOCA/MINOCA; diagnosis and management of spontaneous coronary artery disease; diagnosis and management of Takotsubo cardiomyopathy in women; stress echo in 2022; role of cardiac imaging in cardio-oncology; strain imaging in the echo lab; how to improve efficiency and accuracy in echo using AI; setting up a cardiac sarcoidosis imaging program; modernization of nuclear labs to meet diagnostic needs of women; the role of nuclear imaging in the diagnosis of women with chest pain.

Learning Objectives:
After attending the 9th Annual Role of Cardiac Imaging in Women, attendees will be better able to:
• Identify sex-specific risk factors for cardiovascular disease in women across the life course
• Use risk prediction calculators and risk enhancers to estimate cardiovascular risk in women
• Describe the role of imaging tests to detect subclinical cardiovascular disease
• Describe the maternal risks of HTN in pregnancy
• Explain the appropriate management of HTN in pregnancy
• Outline the latest study findings related to HTN in pregnancy such as the CHAPS trial
• Review the historical data on CVD in Women and identify hurdles to improving outcomes
• Review current guidelines for CVD in Women and implementation of optimal therapies
• Explore the future models for improving CVD in Women, addressing gaps in care and call to action for achieving health equity
• Review the epidemiology and pathophysiology of MINOCA
• Discuss contemporary approaches to diagnosis and management of MINOCA
• Review the epidemiology of INOCA and approach to clinical evaluation and treatment
• Recognize historical clinical features associated with spontaneous coronary artery dissection
• Develop appropriate diagnostic evaluation for patients with probable spontaneous coronary artery dissection
• Identify appropriate physical activity recommendations for patients with prior spontaneous coronary artery dissection
• Describe the current epidemiology of Takotsubo cardiomyopathy
• Select which imaging techniques are important for diagnosis and management in the acute phase
• Select which imaging techniques are important for management and prognosis in the post-acute phase
• Identify the advantages and disadvantages of cardiac imaging modalities used to evaluate cardiac function in cardio-oncology patients
• Define the advantages of strain over LVEF, be aware of its limitations, and apply the use of strain in cardio-oncology
• Characterize the main cardiovascular effects of newer therapies such as TKI and immunotherapy
• Describe the applications of left ventricular strain in patients undergoing chemotherapy
• Discuss the limitations of myocardial strain
• Describe other applications of myocardial strain used in non-oncological patients
• Discuss the use of AI methods for chamber quantification and cardiac function assessment
• Discuss the use of AI methods for augmenting medical decision making
• Compare and contrast ‘black-box’ vs. ‘interpretable AI’ methods for discovering new diagnostic methods and therapies for cardiovascular diseases
• Describe the advantages and limitations of stress echocardiography
• Select the best stress echo measurements and methodology for a given situation
• Analyze and report findings to maximize clinical utility of stress echo
• Review the necessary diagnostic tools in setting up a cardiac sarcoid imaging program
• Describe the importance of a multidisciplinary team in the setting up of a cardiac sarcoid program
• Recognize the need for appropriate management and follow up of patients in a cardiac sarcoid imaging program
• Specify the methods of using novel software, hardware and hybrid imaging in myocardial perfusion SPECT to improve diagnostic accuracy
• Outline the methods of decreasing radiation exposure to patients during myocardial perfusion SPECT imaging
• Describe the advantages of cardiac PET over SPECT in the assessment of CAD in women
• Outline the best diagnostic nuclear imaging strategy for women presenting with stable chest pain
• Illustrate how novel technology in SPECT and PET imaging can be applied in the diagnosis of CAD in women
• Recognize the gender differences in the presentation of chest pain.

Why You Should Attend:
Deborah Heart and Lung Center (Deborah) and Cardiovascular Institute of Philadelphia’s (CVI) 9th Annual Role of Multi-Modality Cardiac Imaging in Women CME Program is designed to further the clinical application, management and interpretation skills of physicians, technologists and mid-level providers involved in non-invasive cardiac imaging. Our agenda features a Keynote Presentation by Dr. Gina Price Lundberg on The Ongoing Burden of Cardiovascular Morbidity and Mortality for Women in 2022. Additional focus topics include:

Assessing CV Risk in Women; Risk & Management of Hypertension in Pregnancy; INOCA & MINOCA; SCAD; Imaging to Diagnose & Manage Takotsubo in Women; Stress Echo in 2022; Cardiac Imaging in Cardio Oncology; Applications of Myocardial Strain Imaging; AI to Improve Efficiency and Accuracy in Echo; Setting Up a Cardiac Sarcoidosis Program; Modernizing Nuclear Lab Equipment and Software to Better Meet the Needs of Women; Role of Nuclear Imaging in Diagnosing Women with Chest Pain.

Attendees will gain valuable knowledge in the role of cardiac imaging in diagnosis and management of women with various cardiac disease states.